估算包裹性腹膜硬化风险需考虑死亡竞争风险
该研究纳入澳大利亚、新西兰(1990-2010)和苏格兰(2000-08)的新成年腹膜透析患者,随访至2012年,使用灵活参数竞争风险模型评估包裹性腹膜硬化(EPS)风险。年龄、原发肾病和透析时间是强烈预测因素,风险预测区分度良好且随透析时间提升。
要点
- 竞争风险分析下EPS风险低于传统Kaplan-Meier法
- EPS风险因国家而异,澳大利亚新西兰低于苏格兰
- 年龄、原发肾病和腹膜透析时间是EPS强烈预测因素
核心结论
- 使用竞争风险分析估算的EPS风险低于传统方法。
- 患者EPS风险具有国家特异性,可用年龄、原发肾病和腹膜透析时间预测。
研究设计与样本
- 研究纳入澳大利亚和新西兰(1990-2010)及苏格兰(2000-08)的新成年腹膜透析患者,随访至2012年。
- 使用灵活参数竞争风险模型评估EPS风险,预测因素包括年龄、透析时间、原发肾病、性别、数据集和糖尿病状态。
主要发现
- EPS在澳大利亚新西兰患者中发生率较低(65例,0.4%),苏格兰患者中较高(34例,2.8%)。
- 竞争风险分析下EPS风险估计值(累积发生率函数=0.0054)低于Kaplan-Meier法(=0.0126)。
- EPS的强烈预测因素包括年龄、原发肾病和腹膜透析时间。
- EPS风险预测在透析开始时区分度中等(C统计量=0.74-0.79),在3年和5年后提升(C统计量=0.81-0.92)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Risk of encapsulating peritoneal sclerosis (EPS) is strongly associated with the duration of peritoneal dialysis (PD), such that patients who have been on PD for some time may consider elective transfer to haemodialysis to mitigate the risk of EPS. There is a need to determine this risk to better inform clinical decision making, but previous studies have not allowed for the competing risk of death. METHODS: This study included new adult PD patients in Australia and New Zealand (ANZ; 1990-2010) or Scotland (2000-08) followed until 2012. Age, time on PD, primary renal disease, gender, data set and diabetic status were evaluated as predictors at the start of PD, then at 3 and 5 years after starting PD using flexible parametric competing risks models. RESULTS: In 17 396 patients (16 162 ANZ, 1234 Scotland), EPS was observed in 99 (0.57%) patients, less frequently in ANZ patients (n = 65; 0.4%) than in Scottish patients (n = 34; 2.8%). The estimated risk of EPS was much lower when the competing risk of death was taken into account (1 Kaplan-Meier = 0.0126, cumulative incidence function = 0.0054). Strong predictors of EPS included age, primary renal disease and time on PD. The risk of EPS was reasonably discriminated at the start of PD (C-statistic = 0.74-0.79) and this improved at 3 and 5 years after starting PD (C-statistic = 0.81-0.92). CONCLUSIONS: EPS risk estimates are lower when calculated using competing risk of death analyses. A patient's estimated risk of EPS is country-specific and can be predicted using age, primary renal disease and duration of PD.
引用
- Lambie M, Teece L, Johnson DW, et al. Estimating risk of encapsulating peritoneal sclerosis accounting for the competing risk of death. Nephrol Dial Transplant. 2019. PMID: 30820552. doi:10.1093/ndt/gfz034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。